BAM
NVO

Byrne Asset Management’s Novo Nordisk NVO Stock Holding History

Byrne Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$114K Buy
3,055
+270
+10% +$12.4K 0.06% 214
2026
Q2 		$134K Hold
2,785
– – 0.07% 206
2026
Q1 		$102K Sell
2,785
-817
-23% -$38.7K 0.06% 222
2025
Q4 		$183K Buy
+3,602
New +$184K 0.1% 141
2025
Q3 		– Hold
0
– – – 116
2025
Q2 		– Sell
-3,802
Closed -$259K – 96
2025
Q1 		$264K Sell
3,802
-365
-9% -$30.1K 0.19% 95
2024
Q4 		$358K Sell
4,167
-193
-4% -$20.9K 0.25% 75
2024
Q3 		$519K Buy
+4,360
New +$581K 0.35% 69
2024
Q2 		– Sell
-4,837
Closed -$641K – 65
2024
Q1 		$621K Buy
4,837
+27
+0.6% +$3.21K 0.43% 67
2023
Q4 		$499K Sell
4,810
-78
-2% -$7.71K 0.38% 71
2023
Q3 		$445K Hold
4,888
– – 0.37% 71
2023
Q2 		$396K Sell
4,888
-190
-4% -$15.5K 0.26% 102
2023
Q1 		$404K Buy
5,078
+38
+0.8% +$2.69K 0.29% 97
2022
Q4 		$341K Sell
5,040
-660
-12% -$38.7K 0.25% 101
2022
Q3 		$284K Hold
5,700
– – 0.22% 101
2022
Q2 		$318K Sell
5,700
-200
-3% -$11.1K 0.23% 86
2022
Q1 		$328K Hold
5,900
– – 0.2% 91
2021
Q4 		$330K Buy
+5,900
New +$320K 0.21% 92

Other funds holding NVO

GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
MCP
Martin Capital Partners Eugene, Oregon $279M AUM 18.87% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EIA
Eastover Investment Advisors Charlotte, North Carolina $257M AUM 14.8% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
NFGCM
Norman Fields Gottscho Capital Management New York $329M AUM 22.06% 1-Year Est. Return
BFA
Benedict Financial Advisors Atlanta, Georgia $504M AUM 20.67% 1-Year Est. Return
HWA
Heartwood Wealth Advisors Richmond, Virginia $1.27B AUM 11.08% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $271M AUM

Byrne Asset Management's NVO Position: Q3 2026 in Review

Byrne Asset Management increased its Novo Nordisk (NVO) stake by 9.7% in Q3 2026, buying an estimated $12.4K and bringing the position to 3,055 shares worth $114K. The position accounts for 0.06% of the portfolio, ranked #214.

Byrne Asset Management first reported a position in NVO in Q4 2021 and has held it in 17 quarters since. The position peaked at $621K in Q1 2024. 64 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Byrne Asset Management held 3,055 shares of Novo Nordisk worth $114K as of Q3 2026.
  • Byrne Asset Management bought 270 Novo Nordisk shares in Q3 2026, an estimated $12.4K.
  • Novo Nordisk made up 0.06% of Byrne Asset Management's portfolio in Q3 2026, its #214 holding.
  • Byrne Asset Management first reported a position in Novo Nordisk in Q4 2021 and has held it in 17 quarters since.
  • Byrne Asset Management's Novo Nordisk position peaked at $621K in Q1 2024.
  • 64 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Byrne Asset Management's 13F filing for Q3 2026, filed 6 Oct 2026.